Time on treatment by best confirmed response (at least PR).^aIndicates data representing dose-escalation cohort (n = 9) and expansion cohort (n = 22) combined. ^bOther reasons for discontinuation were unconfirmed disease progression (n = 3) and withdrawal of consent (n = 1). ^cPatient had progressive disease and withdrew consent.